Clopidogrel active thiol metabolite is formed through 1) a cytochrome P450 (CYP dependent oxidation to a thiolactone : 2-oxoclopidogrel. Then a second CYP dependent oxidation to a sulfenic acid which is reduced by excess glutathione to the active cis -thiol-acid. The 2-oxoclopidogrel is hydrolyzed by paraoxonase PON 1 into an inactive isomer the endo thiol-acid. Thus PON-1 is not involved in the pharmalogical activation of clopidogrel
Antithrombotic thienopyridines, such as clopidogrel and prasugrel, are prodrugs that undergo a metab...
La paraoxonase-1 humaine est une enzyme sérique synthétisée majoritairement dans le foie puis associ...
Contains fulltext : 27457.pdf (publisher's version ) (Open Access)Paraoxonase type...
Clopidogrel is a prodrug bioactivated by cytochrome P450s (CYPs). More recently, paraoxonase-1 (PON1...
Clinical efficacy of the antiplatelet drug clopidogrel is hampered by its variable biotransformation...
In this work, we investigated the formation, reactivity, and antiplatelet activity of various mixed ...
The antithrombotics of the tetrahydrothienopyridine series, clopidogrel and prasugrel, are prodrugs ...
AimsIt is thought that clopidogrel bioactivation and antiplatelet response are related to cytochrome...
The prodrug clopidogrel (Plavix) is activated by cytochrome P450 (P450) to a metabolite that inhibit...
The efficiency and interindividual variability in bioactivation of pra-sugrel and clopidogrel were q...
Clopidogrel is an antiplatelet prodrug that is recommended to reduce the risk of recurrent thrombosi...
Clopidogrel is an antiplatelet prodrug that is recommended to reduce the risk of recurrent thrombosi...
Paraoxonase (PON1) is a liver and plasma enzyme most studied because of its ability to hydrolyze the...
Background: Coronary artery disease (CAD) is one of the leading causes of death worldwide. Clopidogr...
With respect to antiplatelet therapy, randomizedtrials and their meta-analyses1 indicate benefits of...
Antithrombotic thienopyridines, such as clopidogrel and prasugrel, are prodrugs that undergo a metab...
La paraoxonase-1 humaine est une enzyme sérique synthétisée majoritairement dans le foie puis associ...
Contains fulltext : 27457.pdf (publisher's version ) (Open Access)Paraoxonase type...
Clopidogrel is a prodrug bioactivated by cytochrome P450s (CYPs). More recently, paraoxonase-1 (PON1...
Clinical efficacy of the antiplatelet drug clopidogrel is hampered by its variable biotransformation...
In this work, we investigated the formation, reactivity, and antiplatelet activity of various mixed ...
The antithrombotics of the tetrahydrothienopyridine series, clopidogrel and prasugrel, are prodrugs ...
AimsIt is thought that clopidogrel bioactivation and antiplatelet response are related to cytochrome...
The prodrug clopidogrel (Plavix) is activated by cytochrome P450 (P450) to a metabolite that inhibit...
The efficiency and interindividual variability in bioactivation of pra-sugrel and clopidogrel were q...
Clopidogrel is an antiplatelet prodrug that is recommended to reduce the risk of recurrent thrombosi...
Clopidogrel is an antiplatelet prodrug that is recommended to reduce the risk of recurrent thrombosi...
Paraoxonase (PON1) is a liver and plasma enzyme most studied because of its ability to hydrolyze the...
Background: Coronary artery disease (CAD) is one of the leading causes of death worldwide. Clopidogr...
With respect to antiplatelet therapy, randomizedtrials and their meta-analyses1 indicate benefits of...
Antithrombotic thienopyridines, such as clopidogrel and prasugrel, are prodrugs that undergo a metab...
La paraoxonase-1 humaine est une enzyme sérique synthétisée majoritairement dans le foie puis associ...
Contains fulltext : 27457.pdf (publisher's version ) (Open Access)Paraoxonase type...